Abstract
EBV-associated post-transplant lymphoproliferative disorder (PTLD) is a well-recognized complication following solid organ transplantation and hematopoietic stem cell transplantation (HSCT) using bone marrow or peripheral blood as stem cell sources, but rarely reported in umbilical cord blood transplantation (UCBT). We report two cases in unrelated UCBT setting and added the following new information to the literature: (i) EBV-related PTLD can be presented late in recipients of unrelated UCBT; (ii) in contrast to reported literatures that PTLD is a serious complication with unfavorable outcome, especially in monomorphic form, our cases showed that the clinical course may be relatively benign if treatment is initiated promptly.
(c) 2009 Wiley-Liss, Inc.
MeSH terms
-
Acyclovir / therapeutic use
-
Adrenoleukodystrophy / complications
-
Adrenoleukodystrophy / surgery*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Murine-Derived
-
Antiviral Agents / therapeutic use
-
Child
-
Child, Preschool
-
Combined Modality Therapy
-
Cord Blood Stem Cell Transplantation*
-
Cyclosporine / adverse effects
-
Cyclosporine / therapeutic use
-
Epstein-Barr Virus Infections / complications*
-
Epstein-Barr Virus Infections / drug therapy
-
Graft vs Host Disease / drug therapy
-
Herpesvirus 4, Human / physiology
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use
-
Immunologic Factors / therapeutic use
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Lymphoproliferative Disorders / drug therapy
-
Lymphoproliferative Disorders / etiology*
-
Lymphoproliferative Disorders / therapy
-
Lymphoproliferative Disorders / virology
-
Male
-
Postoperative Complications / drug therapy
-
Postoperative Complications / etiology*
-
Postoperative Complications / therapy
-
Postoperative Complications / virology
-
Prednisolone / administration & dosage
-
Prednisolone / adverse effects
-
Prednisolone / therapeutic use
-
Remission Induction
-
Rituximab
-
Tumor Virus Infections / complications*
-
Tumor Virus Infections / drug therapy
-
Virus Activation / drug effects
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Antiviral Agents
-
Immunoglobulins, Intravenous
-
Immunologic Factors
-
Immunosuppressive Agents
-
Rituximab
-
Cyclosporine
-
Prednisolone
-
Acyclovir